Two inventors from L.V. Prasad Eye Institute (LVPEI) in Hyderabad have been granted an Australian patent for a cell therapy that can be used to repair damaged corneas from a variety of corneal ...

Cross-linking CAIRS before implantation makes insertion easier, enhances the flattening effect and eliminates potential ...

Plus, tips from podiatrists and celebrity stylists on how to wear the style. Claudia Willen is a New York-based Associate Editor at Instyle. She has over five years of experience in writing ...

Surgeons restored corneal surfaces in the injured eyes of 14 patients in a small clinical trial. Stem cells from each patient’s healthy eye were cultivated in a lab to grow healthy tissue that could ...

Leave me alone,” read a note posted on the door of 28-year-old Yan Jie’s bedroom. Yan, who shares a flat with a colleague in suburban Shanghai, was mocking himself, saying he was lazy ...

By the first checkup at three months, the corneas of seven (50%) of the participants had been completely restored. By the 12-month mark, that number had increased to 11 (79%) patients.

A limbal stem cell process may restore the corneal surface for patients with debilitating corneal injuries. A novel stem cell therapy demonstrated potential in restoring the corneal surface in ...

WEDNESDAY, March 5, 2025 (HealthDay News) -- Sight-robbing injuries to the cornea can be repaired using a groundbreaking experimental stem cell treatment, a new study shows. The cornea -- the clear ...

Share on Pinterest An experimental stem cell therapy could help reverse corneal damage in people with a vision-threatening eye condition. Image credit: daliloveart/Getty Images. Researchers ...

In research out today, scientists report that an experimental therapy has helped people with otherwise untreatable injuries to their corneas. Researchers at Mass Eye and Ear led the study ...

Novel stem cell therapy repairs 'irreversible' corneal damage in clinical trial Date: March 4, 2025 Source: Mass Eye and Ear Summary: Results from a phase 1/2 clinical trial of a novel stem cell ...